01 November 2016
By Dr Wendy Winnall - PCFA Research Team
Active surveillance provides monitoring of prostate cancer while temporarily avoiding the risk of treatment side effects, such as erectile problems. But men on active surveillance live knowing they have a tumour that is not being treated. These men may benefit from focal therapies. Focal therapies are treatments being developed for prostate cancer that aim to remove the tumour, without needing to remove the whole prostate. The hope is that focal therapies can help prevent cancer progression with minimal side effects.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
